Osimertinib, also known as Tagrisso, is a targeted cancer medication approved for the treatment of non-small cell lung cancer (NSCLC). It has gained significant attention in the medical community due to its effectiveness in treating specific mutations in the EGFR gene. This article aims to provide a comprehensive overview of osimertinib, including its mechanism of action, indications, side...